SCHEMBL32690653

SCHEMBL32690653

O=C(CCCCCCC(=O)Nc1cccc2[nH]c(-c3ccccc3C(F)(F)F)c(O)c(=O)c12)NO

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 11/20 0.42
▸ HDAC3 O15379 9/20 0.42
▸ HDAC6 Q9UBN7 9/20 0.42
▸ HDAC2 Q92769 8/20 0.42
▸ HDAC10 Q969S8 8/20 0.42
▸ NCOR2 Q9Y618 3/20 0.42
▸ HDAC8 Q9BY41 9/20 0.41
▸ HDAC11 Q96DB2 8/20 0.41
▸ HDAC4 P56524 7/20 0.41
▸ HDAC7 Q8WUI4 7/20 0.41
▸ HDAC9 Q9UKV0 7/20 0.41
▸ HDAC5 Q9UQL6 7/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ PARP14 Q460N5 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32690776 1.00 HDAC1 (0.42) HDAC1HDAC3HDAC6HDAC2HDAC10
SCHEMBL32690650 1.00 HDAC1 (0.42) HDAC1HDAC3HDAC6HDAC2HDAC10
SCHEMBL32690837 0.99 HDAC1 (0.41) HDAC1HDAC3HDAC6HDAC2HDAC10
SCHEMBL32690814 0.90 PTPRC (0.41) HDAC1HDAC3HDAC6HDAC2HDAC10
SCHEMBL32690735 0.90 PTPRC (0.41) HDAC1HDAC3HDAC6HDAC2HDAC10
SCHEMBL32690839 0.90 PTPRC (0.41) HDAC1HDAC3HDAC6HDAC2HDAC10
SCHEMBL32690779 0.89 PTPRC (0.41) HDAC1HDAC3HDAC6HDAC2HDAC10
SCHEMBL32690827 0.88 HDAC1 (0.43) HDAC1HDAC3HDAC6HDAC2HDAC10
SCHEMBL32690722 0.88 HDAC1 (0.43) HDAC1HDAC3HDAC6HDAC2HDAC10
SCHEMBL32690674 0.88 HDAC1 (0.43) HDAC1HDAC3HDAC6HDAC2HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition TAIWANJ PHARMACEUTICALS CO LTD (TW) 2026-03-26 — — US claimed
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition TAIWANJ PHARMACEUTICALS CO LTD (TW) 2026-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition NOX1, NOX4, CYBB HDAC1 7/4885HDAC3 9/4885HDAC6 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback